Atlas Trials

Norman B. Gaylis, MD

1 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Norman B. Gaylis, MD

RecordFirmDate
An Evaluation of the Optimal Dose of Tofacitinib Needed to Achieve Low Disease Activity (LDA) or Clinical Remission in Patients With Active Rheumatoid Arthritis (RA) as Measured From a Clinical and Structural Perspective (NCT02566967)Norman B. Gaylis, MD2015-05-01

Track Norman B. Gaylis, MD automatically

Every clearance here is in the API, with alerts when new ones post.